Extracellular Matrix (ECM) Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-05-19　·　168 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 47.8 Mn
2033 年預估規模: USD 81.3 Mn
年複合成長率 CAGR: 7.9%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights 產業別 Healthcare & Life Sciences出版日期 2026-05-19頁數 168報告編號 CMI6171

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Extracellular Matrix (ECM) Market, By Product (Extracellular Matrix Kits, Decellularized ECM, Hydrogels, ECM Scaffolds, and Others), By Component (Glycoproteins, Fibrous Proteins, Proteoglycans, and Others), By Matrix Type (Basement membrane and Interstitial matrix), By Source (Animal-Derived ECM, Human-Derived ECM, and Synthetic ECM), By Application (Regenerative Medicine, Tissue Engineering, Wound Healing, and Others), By End User (Biopharmaceutical Companies, Research Institutes, Contract Research Organization, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

報告摘要

The global extracellular matrix (ECM) market is estimated to be valued at USD 47.8 Mn in 2026 and is expected to reach USD 81.3 Mn by 2033, exhibiting a compound annual growth rate (CAGR) of 7.9% from 2026 to 2033. The Extracellular Matrix (ECM) is a segment of the biotechnology market that is witnessing significant growth. The market includes natural and synthetic extracellular matrices and biomaterials that are used in the regrowth and healing of tissues. Natural ECMs are formed using decellularization techniques and have the unique ability to retain their three-dimensional structure along with the biological factors that stimulate cell attachment, multiplication, and differentiation. Extracellular matrices serve an important purpose within different fields of medicine, including orthopedic and cardiovascular surgery, wound healing therapies, and aesthetic medicine. Currently, there are several types of market products, which include collagen-based ECMs, hyaluronic acid products, fibrin matrices, and xenogenic/allogenic tissue matrices. They have found application in surgery mesh enhancement, dermal substitutes, cartilage replacement therapy, vascular grafts, and neural tissue engineering. Some of the reasons that promote market growth include increasing prevalence of chronic wounds, an aging population, minimally invasive procedures' popularity, and advanced technology in tissue engineering. ECMs can be regarded as promising medical solutions that facilitate natural tissue regrowth without any risks posed by synthetic biomaterials. Market Dynamics The global extracellular matrix (ECM) market has gained traction due to the growing number of cases of chronic diseases and injuries that require wound-healing products. Secondly, there is an aging population, which means there is need for efficient ways to regenerate and repair tissues. Thirdly, there is preference for less invasive surgeries, and awareness about the benefits of using biological matrices compared to artificial substitutes. Finally, developments in the fields of tissue engineering, bioprocessing, and decellularization technologies offer new possibilities for ECM products. Despite the above factors driving growth, some constraints exist in the form of strict regulatory requirements, making clinical trials both lengthy and expensive. The relative expensive nature of ECM products compared to other forms of conventional medical treatments poses difficulties in accessing them in developing economies. Further, infection risks and immunogenicity problems could be some limitations. Lastly, preservation of biological tissues could pose some limitations. In spite of the above constraints, there are many opportunities available in the market in terms of applications in aesthetic medicine, personalized medicine, 3D bioprinting, and tissue engineering. Chronic diseases in patients will result in higher costs for healthcare services in developing countries. Finally, scientific institutions' cooperation with industry players is a good opportunity for promoting ECM products. Key Features of the Study • This report provides in-depth analysis of the global extracellular matrix (ECM) market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global extracellular matrix (ECM) market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Thermo Fisher Scientific, Corning Incorporated, Baxter International, Integra LifeSciences, FUJIFILM Holdings Corporation, Merck KGaA, Advanced BioMatrix, REPROCELL USA, BioLamina AB, and Tissue Regenix • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global extracellular matrix (ECM) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global extracellular matrix (ECM) market Market Segmentation • Product Insights (Revenue, USD Mn, 2021 - 2033) o Extracellular Matrix Kits o Decellularized ECM o Hydrogels o ECM Scaffolds o Others • Component Insights (Revenue, USD Mn, 2021 - 2033) o Glycoproteins o Fibrous Proteins o Proteoglycans o Others • Matrix Type Insights (Revenue, USD Mn, 2021 - 2033) o Basement membrane o Interstitial matrix • Source Insights (Revenue, USD Mn, 2021 - 2033) o Animal-Derived ECM o Human-Derived ECM o Synthetic ECM • Application Insights (Revenue, USD Mn, 2021 - 2033) o Regenerative Medicine o Tissue Engineering o Wound Healing o Others • End User Insights (Revenue, USD Mn, 2021 - 2033) o Biopharmaceutical Companies o Research Institutes o Contract Research Organization o Others • Regional Insights (Revenue, USD Mn, 2021 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o Thermo Fisher Scientific o Corning Incorporated o Baxter International o Integra LifeSciences o FUJIFILM Holdings Corporation o Merck KGaA o Advanced BioMatrix o REPROCELL USA o BioLamina AB o Tissue Regenix

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Global Extracellular Matrix (ECM) Market, By Product  Global Extracellular Matrix (ECM) Market, By Component  Global Extracellular Matrix (ECM) Market, By Matrix Type  Global Extracellular Matrix (ECM) Market, By Source  Global Extracellular Matrix (ECM) Market, By Application  Global Extracellular Matrix (ECM) Market, By End User  Global Extracellular Matrix (ECM) Market, By Region 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Impact Analysis o Key Highlights o Regulatory Scenario o Product Launches/Approvals o PEST Analysis o PORTER’s Analysis o Market Opportunities o Regulatory Scenario o Key Developments o Industry Trends 4. Global Extracellular Matrix (ECM) Market, By Product, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022- 2033  Segment Trends o Extracellular Matrix Kits  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Decellularized ECM  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Hydrogels  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o ECM Scaffolds  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 5. Global Extracellular Matrix (ECM) Market, By Component, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022- 2033  Segment Trends o Glycoproteins  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Fibrous Proteins  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Proteoglycans  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 6. Global Extracellular Matrix (ECM) Market, By Matrix Type, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022- 2033  Segment Trends o Basement membrane  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Interstitial matrix  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 7. Global Extracellular Matrix (ECM) Market, By Source, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022- 2033  Segment Trends o Animal-Derived ECM  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Human-Derived ECM  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Synthetic ECM  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 8. Global Extracellular Matrix (ECM) Market, By Application, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022- 2033  Segment Trends o Regenerative Medicine  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Tissue Engineering  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Wound Healing  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 9. Global Extracellular Matrix (ECM) Market, By End User, 2021-2033, (USD Mn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022- 2033  Segment Trends o Biopharmaceutical Companies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Research Institutes  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Contract Research Organization  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn) 10. Global Extracellular Matrix (ECM) Market, By Region, 2021- 2033, Value (USD Mn) o Introduction  Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)  Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)  Regional Trends o North America  Introduction  Market Size and Forecast, By Product, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By Component, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By Matrix Type, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By Source, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021- 2033, Value (USD Mn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, By Product, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By Component, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By Matrix Type, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By Source, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021- 2033, Value (USD Mn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Introduction  Market Size and Forecast, By Product, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By Component, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By Matrix Type, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By Source, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021- 2033, Value (USD Mn) o Germany o U.K. o Spain o France o Italy o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, By Product, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By Component, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By Matrix Type, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By Source, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021- 2033, Value (USD Mn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, By Product, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By Component, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By Matrix Type, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By Source, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By Country, 2021- 2033, Value (USD Mn) o GCC Countries o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, By Product, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By Component, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By Matrix Type, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By Source, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By Application, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By End User, 2021- 2033, Value (USD Mn)  Market Size and Forecast, By Country/Region, 2021- 2033, Value (USD Mn) o South Africa o North Africa o Central Africa 11. Competitive Landscape o Thermo Fisher Scientific  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Corning Incorporated  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Baxter International  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Integra LifeSciences  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o FUJIFILM Holdings Corporation  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Merck KGaA  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Advanced BioMatrix  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o REPROCELL USA  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o BioLamina AB  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Tissue Regenix  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies 12. Analyst Recommendations o Wheel of Fortune o Analyst View o Coherent Opportunity Map 13. References and Research Methodology o References o Research Methodology o About us *Browse 32 market data tables and 28 figures on Extracellular Matrix (ECM) Market' - Global forecast to 2033

提及公司

Thermo Fisher ScientificCorning IncorporatedBaxter InternationalIntegra LifeSciencesFUJIFILM Holdings CorporationMerck KGaAAdvanced BioMatrixREPROCELL USABioLamina ABTissue Regenix

同分類最新報告（醫療與生命科學）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們